Topic
AI Agents
(Preview) Astra (and AGI?) Arrives, Meta’s Muse and the Agent Opportunity, Anthropic and the Revival of (P)Doom Angst
Ben Thompson and Andrew Sharp focus on OpenAI’s Astra as a turning point for agents, especially computer-use systems that can operate software directly. They also connect note-taking, memory, and Markdown to a broader theory of why LLMs feel more useful, then widen out to safety, benchmarks, TPU vs. Blackwell infrastructure, and the implications for software moats.
20VC: NVIDIA Crushes Quarter and Buys Hugging Face | OpenAI Cuts Off Cursor | Instinct Hits $2.5BN Valuation and The Race for AI Assistants | Cognition Raises at $46BN, Linear $2.5BN and Clay $7BN
This episode focuses on the AI stack’s accelerating power-law dynamics: Nvidia’s demand and supply constraints, OpenAI’s conflict with Cursor, and the emerging security risks from autonomous agents. The second half zooms out to how AI is reshaping software products, with Instinct, Cognition, Salesforce, Clay, and Linear all used as examples of an agent-native market reset.
Inside an AI-powered personal dashboard | Matthew Tiemann
Matthew Tiemann describes building personal AI systems that reduce friction in knowledge work, from dashboarding and forecasting to software and game development. The conversation focuses on proactive agents, 12-hour human check-ins, and the limits of automation for subjective creative tasks.
Leopold Blows Up, OpenAI Drastically Cuts Prices, Microsoft’s Best Day
Leopold Aschenbrenner’s AI-focused hedge fund reportedly unwound much of its public stock book after a brutal leveraged drawdown, sparking debate over whether effective-altruist style conviction trading is too risky. The rest of the episode covers OpenAI’s sharp price cuts, Nvidia’s investment in Safe Superintelligence, and how Microsoft, Amazon, Google, Meta, and Apple are being reshaped by the AI capex cycle.
20VC: $5BN in Revenue, 7 to 7,000 Employees in 9 Months, 206,000 Tests in a Single Day: The Craziest Story in Startups: Curative with Fred Turner
Fred Turner tells the wild Curative story: a spare-time COVID test became a $5B revenue machine that scaled from 7 to 7,000 employees and 206,000 daily tests at peak. The episode then moves into Curative’s pivot to health insurance, aggressive AI automation, and Turner’s broader thesis that agents, not software vendors, will reshape regulated industries.